Product NDC: | 0615-7625 |
Proprietary Name: | Fluoxetine |
Non Proprietary Name: | Fluoxetine |
Active Ingredient(s): | 20 mg/1 & nbsp; Fluoxetine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0615-7625 |
Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076001 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120320 |
Package NDC: | 0615-7625-31 |
Package Description: | 31 CAPSULE in 1 BLISTER PACK (0615-7625-31) |
NDC Code | 0615-7625-31 |
Proprietary Name | Fluoxetine |
Package Description | 31 CAPSULE in 1 BLISTER PACK (0615-7625-31) |
Product NDC | 0615-7625 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fluoxetine |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120320 |
Marketing Category Name | ANDA |
Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
Substance Name | FLUOXETINE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |